Anti‑Mullerian Hormone (AMH), Female
Also known as: Mullerian Inhibiting Substance, AMH/MIS
Use
This test measures anti‑Mullerian hormone (AMH) levels in female serum to evaluate ovarian reserve by approximating the number of eggs in a woman’s ovaries. It is commonly used by women trying to conceive, planning pregnancy, undergoing fertility treatments such as IVF, to assess ovarian function after cancer therapy, or to help evaluate conditions such as polycystic ovary syndrome (PCOS). AMH levels decline with age and can signal diminished ovarian reserve, though the test does not directly predict fertility. Higher levels may indicate better ovarian response, while lower levels suggest fewer eggs and possible reduced ovarian reserve. ([questhealth.com](https://www.questhealth.com/product/amh-marker-test/37227M.html?utm_source=openai))
Special Instructions
Not provided.
Limitations
AMH levels can be influenced by hormone therapy or hormonal birth control, potentially reducing the measured value. The test is a snapshot and does not predict actual fertility outcomes—other factors such as ovulation, tubal patency, uterine factors, and partner sperm quality are critical. Elevated AMH may be seen in PCOS, and interpretation should be done in clinical context. ([questhealth.com](https://www.questhealth.com/product/amh-marker-test/37227M.html?utm_source=openai))
Methodology
Immunoassay
Biomarkers
Anti‑Mullerian Hormone (AMH)
Analyte
Result Turnaround Time
2-4 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
0.5 mL
Minimum Volume
0.3 mL
Container
Red Top (No Additive)
Patient Preparation
No special preparation required
Causes for Rejection
Lipemia; Hemolysis
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 24 Hours |
| Refrigerated | 6 Days |
| Frozen | 28 Days |
Other tests from different labs that may be relevant